Interpace Biosciences, Inc. (IDXG)

OTCMKTS · Delayed Price · Currency is USD

1.998

+0.003 (0.13%)

Apr 22, 2026, 1:25 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Developing and Selling Clinical and Pharma Services	38.73M	46.93M	40.04M	31.84M	33.12M
Developing and Selling Clinical and Pharma Services Growth	-17.47%	17.21%	25.75%	-3.86%	2.22%
Total	38.73M	46.93M	40.04M	31.84M	33.12M
Total Growth	-17.47%	17.21%	25.75%	-3.86%	2.22%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	38.73M	46.93M	40.04M	31.84M	33.12M
United States Growth	-17.47%	17.21%	25.75%	-3.86%	2.22%
Total	38.73M	46.93M	40.04M	31.84M	33.12M
Total Growth	-17.47%	17.21%	25.75%	-3.86%	2.22%

Source: S&P Global Market Intelligence.